Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas. [electronic resource]
Producer: 19890921Description: S48-50 p. digitalISSN:- 0344-5704
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Clinical Trials as Topic
- Cyclophosphamide -- administration & dosage
- Dactinomycin -- administration & dosage
- Doxorubicin -- administration & dosage
- Humans
- Ifosfamide -- administration & dosage
- Remission Induction
- Rhabdomyosarcoma -- drug therapy
- Soft Tissue Neoplasms -- drug therapy
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.